Rheumatology · IL-6 receptor antagonist
Tocilizumab
Dose
162 mg SC weekly, or 8 mg/kg IV every 4 weeks.
Use
RA, giant cell arteritis (steroid-sparing), cytokine release syndrome.
Monitoring
Neutrophils, platelets, LFTs and lipids at 4–8 weeks then periodically.
Side effects
- • Neutropenia
- • Transaminitis
- • Hyperlipidaemia
- • GI perforation risk with diverticulitis
Related in WardRound
Always confirm dose against your local formulary / BNF before prescribing.
